Rhythm Pharmaceuticals Stock
Rhythm Pharmaceuticals Stock
With 41 Buy predictions and not a single Sell prediction Rhythm Pharmaceuticals is an absolute favorite of our community.
As a result the target price of 109 € shows a positive potential of 49.32% compared to the current price of 73.0 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | - | -2.667% | -8.176% | 41.748% | -21.925% | 362.025% | 314.773% |
| Heron Therapeutics Inc. | -0.770% | 1.801% | -17.992% | -58.805% | -36.580% | -66.357% | -95.128% |
| Evolus Inc | -0.560% | 2.890% | -21.586% | -60.663% | -34.679% | -51.892% | -68.214% |
| Sangamo Therapeutics Inc. | -1.650% | -15.717% | -38.107% | -65.898% | -36.993% | -85.186% | -97.618% |
Comments
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $110.00 to $100.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat